This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
3 of the Best Efficient Stocks to Boost Your Portfolio
by Tirthankar Chakraborty
Delta Apparel (DLA), MEDIFAST (MED) & Service Corporation International (SCI) are at present the three top efficient stocks that need to be added to your portfolio.
Altria (MO) Benefits From Low-Risk Products, High Pricing
by Zacks Equity Research
Altria (MO) is gaining from rising popularity of IQOS and on!. Strong pricing for tobacco products is also driving revenue growth.
Medifast (MED) Looks Tempting: Rallies More Than 35% in a Year
by Zacks Equity Research
Medifast (MED) has been benefiting from the strength of its OPTAVIA lifestyle solution and coaching support system as well as strategic growth endeavors like technological advancements.
Brown-Forman (BF.B) Q1 Earnings Meet Estimates, Sales Increase
by Zacks Equity Research
Brown-Forman's (BF.B) Q1 results gain from growth across geographic regions, product categories and the Travel Retail channel.
Philip Morris (PM) Gains on IQOS, Beyond Nicotine Expansion
by Zacks Equity Research
Philip Morris (PM) is gaining from rising popularity of IQOS devices. The company is also progressing with the expansion of Beyond Nicotine products that cater to medical wellness.
3 Reasons Why Growth Investors Shouldn't Overlook Medifast (MED)
by Zacks Equity Research
Medifast (MED) could produce exceptional returns because of its solid growth attributes.
Altria (MO) Hikes Dividend, Boosts Shareholders' Wealth
by Zacks Equity Research
Altria (MO) raises quarterly dividend by 4.7% to 90 cents per share. The company's new annualized dividend rate is $3.60 per share.
Hain Celestial (HAIN) Q4 Earnings Miss Estimates, Sales Down
by Zacks Equity Research
Hain Celestial's (HAIN) fourth-quarter performance reflects impacts of overlapping pandemic-led volume surge witnessed in the prior-year quarter.
The J.M. Smucker (SJM) Q1 Earnings Beat Estimates, Decline Y/Y
by Zacks Equity Research
The J.M. Smucker's (SJM) first-quarter fiscal 2022 results reflect lower earnings and sales. Results were hurt by divestiture impacts and cost inflation, which is likely to prevail.
Church & Dwight (CHD) Gains on High Demand Amid Cost Concerns
by Zacks Equity Research
Church & Dwight (CHD) has been benefiting from elevated demand amid the pandemic, including online. That said, elevated input costs and supply-chain headwinds weighed on its 2021 view.
Zacks.com featured highlights include: Deckers Outdoor, Medifast, Textron, Terex Corp and Sonos
by Zacks Equity Research
Zacks.com featured highlights include: Deckers Outdoor, Medifast, Textron, Terex Corp and Sonos
5 Top-Ranked Liquid Stocks to Bet on for Higher Returns in 2021
by Vaishali Doshi
Here are five top-performing liquid stocks, Deckers (DECK), Medifast (MED), Textron (TXT), Terex (TEX) and Sonos (SONO), which investors can consider for healthy returns.
Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
Mondelez (MDLZ) Teams Up With MissFresh, Fuels China Expansion
by Zacks Equity Research
Mondelez (MDLZ) teams up with MissFresh to offer Oreo Zero on the latter's popular online retail platform. This will give online customers of China access to OREO's new sugar-free sandwiches.
SpartanNash's (SPTN) Earnings Beat in Q2, Sales Decline Y/Y
by Zacks Equity Research
SpartanNash (SPTN) posts weak sales in the second quarter of 2021 due to favorable sales in the previous year on higher pandemic-led demand.
Buy 5 Top-Ranked Efficient Stocks for a Solid Portfolio
by Tirthankar Chakraborty
MEDIFAST (MED), Smith & Wesson Brands (SWBI), Encore Wire (WIRE), Cavco Industries (CVCO) & Apple (AAPL) at present flaunt solid efficiency levels and are thus believed to provide stellar returns in the near future.
Medifast (MED) Loses 13.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Medifast (MED) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Medifast (MED) Fuels Digital Growth With OPTAVIA App Launch
by Zacks Equity Research
Medifast (MED) launches the OPTAVIA app, which is likely to enhance Clients' experience with Lean & Green recipes, along with access to past order record and account information among other things.
Zacks.com featured highlights include: Piper Sandler, Mueller Industries, Global Ship Lease, Medifast and Bassett Furniture
by Zacks Equity Research
Zacks.com featured highlights include: Piper Sandler, Mueller Industries, Global Ship Lease, Medifast and Bassett Furniture
Philip Morris (PM) Boosts Beyond Nicotine Options With OtiTopic
by Zacks Equity Research
Philip Morris (PM) acquires OtiTopic to expand offerings in the inhaled therapeutics and respiratory drug delivery platform. The move is part of the company's Beyond Nicotine strategy.
Inter Parfums (IPAR) Q2 Earnings Top Estimates, Sales up Y/Y
by Zacks Equity Research
Inter Parfums' (IPAR) second-quarter 2021 results reflect solid top-and bottom-line performance on growth in U.S. and European operations.
Sysco (SYY) Q4 Earnings & Revenues Top Estimates, View Raised
by Zacks Equity Research
Sysco's (SYY) fourth-quarter fiscal 2021 results reflect increased top and bottom lines as certain markets are reopening. Management lifts EPS view for fiscal 2022.
5 Top Rated Stocks to Pick With Solid Net Profit Margins
by Anirudha Bhagat
Let's take a look at the five top ranked stocks with stellar net profit margins for a winning portfolio.
Tyson Foods (TSN) Q3 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Tyson Foods' (TSN) third-quarter fiscal 2021 sales and earnings rise year over year on revenue growth across all segments. However, pandemic-induced cost is a headwind.
Zacks.com featured highlights include: Magnolia Oil & Gas, Medifast, Textron, ConocoPhillips and Steven Madden
by Zacks Equity Research
Zacks.com featured highlights include: Magnolia Oil & Gas, Medifast, Textron, ConocoPhillips and Steven Madden